Skip to main content
SpringerLink
Log in

Lareb and ADHD patients collaborate on drug use and ADRs

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Weits G, et al. Collaboration between patient and pharmacovigilance organizations to gain insight into adults' experiences with drug use and ADRs for the treatment of ADHD Expert Opinion on Drug Safety 18: 333-337, No. 4, 14 Mar 2019. Available from: URL: https://doi.org/10.1080/14740338.2019.1591366

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lareb and ADHD patients collaborate on drug use and ADRs. PharmacoEcon Outcomes News 827, 23 (2019). https://doi.org/10.1007/s40274-019-5861-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-019-5861-2

Search

Navigation